These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 18068146

  • 1. Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials.
    Pitsouni E, Iavazzo C, Falagas ME.
    Am J Obstet Gynecol; 2008 Feb; 198(2):153-60. PubMed ID: 18068146
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
    Seidman LS, Skokos CK.
    Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
    Vardakas KZ, Michalopoulos A, Falagas ME.
    Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959
    [Abstract] [Full Text] [Related]

  • 7. Clinical and mycological efficacy of single-day oral treatment with itraconazole (400 mg) in acute vulvovaginal candidosis.
    Urünsak M, Ilkit M, Evrüke C, Urünsak I.
    Mycoses; 2004 Oct; 47(9-10):422-7. PubMed ID: 15504127
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative study on the effectiveness of antifungal agents in different regimens against vaginal candidiasis.
    Mikamo H, Kawazoe K, Sato Y, Hayasaki Y, Tamaya T.
    Chemotherapy; 1998 Oct; 44(5):364-8. PubMed ID: 9732153
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N.
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Terbinafine versus itraconazole and fluconazole in the treatment of Vulvovaginal candidiasis.
    Ferahbas A, Koc AN, Uksal U, Aygen E, Mistik S, Yildiz S.
    Am J Ther; 2006 Feb; 13(4):332-6. PubMed ID: 16858169
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G, Di Lorenzo G.
    Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
    [Abstract] [Full Text] [Related]

  • 20. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence.
    Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME.
    J Womens Health (Larchmt); 2011 Aug; 20(8):1245-55. PubMed ID: 21774671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.